U.S. physicians move to
more flexible mammogram schedule
Send a link to a friend
[June 23, 2017] By
Andrew M. Seaman
NEW YORK (Reuters Health) - Women at
average risk for breast cancer should be offered screening mammograms
every year or two starting at age 40 and they should start regular
screening no later than age 50, an influential U.S. group of
obstetricians and gynecologists said on Thursday.
|
Amid divided expert opinions on whether more screenings are
beneficial, the American College of Obstetricians and Gynecologists
(ACOG), which previously recommended yearly screenings starting at
age 40, wants to stress shared decision-making between women and
their doctors based on their personal preferences in the new, more
flexible schedule.
The updated recommendation is more in line with other prominent
organizations, including the American Cancer Society and the U.S.
Preventive Services Task Force.
"We want women to feel empowered that they are participants in this
process and that their values and preferences are an important part
of the decision-making process," said Dr. Christopher Zahn, who is
ACOG'S vice president of practice.
The updated recommendations pose yet another change in the already
complex landscape of guidelines suggesting when women of average
risk should begin breast cancer screening.
The 2016 guidelines from the U.S. Preventive Services Task Force
recommends screening mammograms every other year starting at age 50,
but offers women the option to begin screening at age 40. The
American Cancer Society recommends screening should be offered
starting at age 40, but it recommends annual screening beginning at
age 45, then tapering off to screening every other year starting at
age 55.
Dr. Otis Brawley, chief medical officer for the American Cancer
Society, said the recommendations of the various groups may be
confusing but they are more evidence-based than decades ago.
[to top of second column] |
"Medicine is getting much more interested in what the evidence
actually shows," he said.
Brawley said there is likely a group of women in their 40s who will
benefit from mammography screenings, but there is also a group that
will likely be inconvenienced and possibly harmed during follow-up
testing.
"One needs to weigh the benefits and harms and make a decision you
feel comfortable with," Brawley said.
For example, one woman may feel the possible harms of excessive
worry or overtreatment are outweighed by a lower risk of death from
breast cancer, while a younger woman may say the slightly decreased
risk of death is not worth the trouble.
"What we’re saying is that the patient really needs to be involved
in that decision," Zahn said.
SOURCE: http://bit.ly/17GRJIo Obstetrics and Gynecology, online June
22, 2017.
(Reporting by Andrew Seaman in New York; Editing by Marguerita Choy)
[© 2017 Thomson Reuters. All rights
reserved.] Copyright 2017 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed. |